EP Patent

EP1961414A1 — A controlled release composition comprising a recombinant gelatin

Assigned to Fujifilm Manufacturing Europe BV · Expires 2008-08-27 · 18y expired

What this patent protects

The invention relates to the field of pharmacology. More specific, the invention relates to a controlled release composition. In one of the embodiments, the invention provides a method for preparing a controlled release composition comprising the steps of: - providing a solution…

USPTO Abstract

The invention relates to the field of pharmacology. More specific, the invention relates to a controlled release composition. In one of the embodiments, the invention provides a method for preparing a controlled release composition comprising the steps of: - providing a solution of a recombinant gelatin and a pharmaceutical - chemically cross-linking said recombinant gelatin to obtain a three dimensional structure.

Drugs covered by this patent

Patent Metadata

Patent number
EP1961414A1
Jurisdiction
EP
Classification
Expires
2008-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Fujifilm Manufacturing Europe BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.